Menu
- Home
- Coronavirus
- Support
- Education
- Advocacy
- Research
×
Tag
Do you use abatacept (Orencia®) to treat your inflammatory arthritis? We have been alerted about an anticipated shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations of abatacept. Here’s what you need to do.
Additional 2023 COVID-19 vaccination booster doses are now available for eligible Australians. Is it time you recharged your protection?
Updated advice from the Australian Rheumatology Association about the timing and use of COVID-19 vaccines for rheumatology patients.
Medicinal cannabis has been legal in Australia since 2016. However, access is still limited and more data is needed to determine its benefits for many conditions.
Do you use Orencia to treat your inflammatory arthritis? Have you been affected by the current supply shortage? Here are the options available to you.
How can Australians with autoimmune arthritis access a COVID-19 vaccine? Learn more about your eligibility and the evidence you will need to provide.
Global researchers are interested in learning how people with rheumatic disease make decisions regarding vaccines in light of their rheumatic disease.
Rheumatoid arthritis pain isn’t easy to manage when providers can’t see and touch your joints in person, but you can discuss and treat RA pain during telehealth visits. Here’s how.
Held virtually, the 2020 medical meeting from the European League Against Rheumatism shared important medical breakthroughs and updates about managing rheumatic conditions.
Upadacitinib (Rinvoq®) is a new treatment option now available for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.